WORK WITH US
SB 367 – Requires Community College Districts And The California State University Campuses To Include Information Regarding Opioid Overdose And Reversal Medication In Campus Orientations; And Requires Health Centers Of The Respective Campuses Apply To Be Approved To Use Opioid Overdose Reversal Medication
This bill requires the governing board of each community college district and the Trustees of the California State University to provide as part of established campus orientations, educational and preventive information provided by the State Department of Public Health about opioid overdose and the use and location of opioid overdose reversal medication to students at all campuses of their respective segments. The bill requires campuses to collaborate with campus-based and community-based recovery advocacy organizations in providing the required information.
The bill further requires that each campus health center located in a community college district or on a California State University campus apply to use the statewide standing order issued by the State Public Health Officer to distribute dosages of a federally approved opioid overdose reversal medication. The bill also requires these campuses to participate in the Naloxone Distribution Project administered by the State Department of Health Care Services. Upon approval for use of the statewide standing order and participation in the Naloxone Distribution Project, a campus health center shall distribute a federally approved opioid overdose reversal medication obtained through the Naloxone Distribution Project in accordance with its terms and conditions.
The bill requests the Regents of the University of California also comply with the provisions of this bill.
(SB 367 adds Section 67384 to the Education Code.)